Ibum Zatoki Max

Pseudoephedrine Hydrochloride and Ibuprofen, the active ingredients in Ibum Zatoki Max, are a decongestant and a nonsteroidal anti‑inflammatory drug presented as an oral formulation for systemic use. The combination relieves nasal congestion, reduces fever, and eases mild to moderate pain in adults and adolescents.

GNH USA supplies Ibum Zatoki Max as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibum Zatoki Max combines a nasal decongestant and an NSAID, addressing conditions involving congestion, pain, and fever.

- Nasal congestion: reduces swelling of nasal passages to improve airflow. - Headache: alleviates pain by decreasing inflammatory mediators. - Fever: lowers elevated body temperature through prostaglandin inhibition. - Mild to moderate pain: provides analgesia for musculoskeletal or dental discomfort.

Common Side Effects: - Nausea: mild stomach upset after oral intake. - Dizziness: transient light‑headedness, especially on standing. - Insomnia: difficulty falling asleep due to stimulant effect. - Dry mouth: reduced salivation. - Headache: occasional tension‑type headache. - Increased blood pressure: modest rise in systolic/diastolic values.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Gastrointestinal bleeding: black stools or vomiting blood. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: reduced urine output or swelling. - Cardiovascular events: chest pain, arrhythmia, or stroke. - Hepatic dysfunction: jaundice or elevated liver enzymes.

Before using Ibum Zatoki Max, consider the following precautions: - Cardiovascular assessment: monitor blood pressure due to pseudoephedrine’s vasoconstrictive action. - Gastrointestinal risk: avoid in patients with active ulcers or a history of bleeding. - Renal function: adjust use in moderate to severe kidney disease. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: review concomitant medications for potential conflicts. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Ibum Zatoki Max may interact with several medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Anticoagulants (e.g., warfarin): increased bleeding risk from ibuprofen. - Other NSAIDs: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding potential. - Antihypertensive agents: reduced efficacy due to pseudoephedrine.

Moderate Interactions (Monitor Closely): - Diuretics: possible electrolyte imbalance. - Beta‑blockers: may blunt pseudoephedrine’s cardiovascular effects. - Lithium: pseudoephedrine can raise lithium levels. - Alcohol: enhances gastrointestinal irritation. - Corticosteroids: increased risk of ulceration.